Observational Study of Alcoholic Liver Disease
This observational study aims to collect biological samples (like blood and urine) from people with Alcoholic Liver Disease (ALD) and healthy individuals. The goal is to create a resource of samples that researchers can use to better understand ALD and develop new treatments. You might be able to join if you are between 18 and 75 years old and have alcoholic steatosis (fat accumulation in the liver due to alcohol abuse) without significant scarring or inflammation. You would also need to show abnormal liver blood tests. This study is considered successful if it successfully builds this collection of samples over five years. The current recruitment status is unclear.
- Study design
- This is an observational study planning to enroll 500 participants. It compares individuals with Alcoholic Liver Disease to healthy controls.
- What's involved
- You would have a one-time blood draw. The study aims to collect samples over a five-year period.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Comparison of ALD, NASH, and Healthy Control Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Srinivisan Dasarathy, MD · PRINCIPAL_INVESTIGATOR · Staff
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- BiorepositoryThis is a 5 year study
The goal of this study is to create a biorepository of samples from patients with different types of liver disease compared to each other and healthy controls